Results 181 to 190 of about 765,759 (204)

Trends in kinase drug discovery: targets, indications and inhibitor design

Nature Reviews Drug Discovery, 2021
Misty M Attwood, Stefan Knapp
exaly  

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Cell, 2020
Markus Hoffmann, Nadine Krüger, Tobias S Schiergens   +2 more
exaly  

Inhibitor of Apoptosis Proteins

2006
openaire   +1 more source

A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia

Cancer Cell, 2019
Andrei V Krivtsov, Jayant Y Gadrey, Charlie Hatton   +2 more
exaly  

Inhibitor of Apoptosis Protein

2018
openaire   +1 more source

Purification and Use of Recombinant Inhibitor of Apoptosis Proteins as Caspase Inhibitors

2000
Q L, Deveraux, K, Welsh, J C, Reed
openaire   +2 more sources

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Nature Reviews Cancer, 2019
Jonathan J Havel, Diego Chowell, Timothy A Chan   +2 more
exaly  

Inhibitor of Apoptosis Protein

2006
openaire   +1 more source

Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial

Lancet, The, 2007
Vivian Wing Yan Lee, Wai Keung Leung, James Yun Wong Lau   +2 more
exaly  

Inhibitor of Apoptosis (IAP) Proteins

2012
openaire   +1 more source